SCHEMBL325104

SCHEMBL325104

CC1CCCC1c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GRIA4 P48058 2/20 0.45
MAOB P27338 8/20 0.43
MAOA P21397 7/20 0.43
KDM1A O60341 5/20 0.43
CYP2C19 P33261 4/20 0.43
CYP2B6 P20813 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
LMNA P02545 2/20 0.43
TAAR1 Q96RJ0 2/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
CYP2A6 P11509 1/20 0.43
SLC6A2 P23975 1/20 0.43
HTR2C P28335 1/20 0.43
ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16830124 1.00 MEN1 (0.46) MEN1KMT2AGRIA4MAOBMAOA
SCHEMBL16830132 1.00 MEN1 (0.46) MEN1KMT2AGRIA4MAOBMAOA
SCHEMBL16830133 1.00 MEN1 (0.46) MEN1KMT2AGRIA4MAOBMAOA
SCHEMBL16830122 1.00 MEN1 (0.46) MEN1KMT2AGRIA4MAOBMAOA
SCHEMBL2496586 0.95 MEN1 (0.50) MEN1KMT2AMAOBMAOAKDM1A
SCHEMBL19207129 0.93 MEN1 (0.48) MEN1KMT2AMAOBMAOAKDM1A
SCHEMBL18092984 0.88 KDM1A (0.50) MEN1KMT2AGRIA4MAOBKDM1A
SCHEMBL5680394 0.87 MEN1 (0.43) MEN1KMT2AGRIA4MAOBMAOA
SCHEMBL5680388 0.84 GRIA4 (0.41) MEN1KMT2AGRIA4MAOBMAOA
SCHEMBL18092985 0.84 SLC6A2 (0.53) MEN1KMT2AMAOBKDM1ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10259759-B2 Cyclohexylbenzene composition EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-04-16 US claimed
US-9908829-B2 Process for making phenol and/or cyclohexanone EXXONMOBIL CHEMICAL PATENTS INC. (US) 2018-03-06 US claimed
US-20170057895-A1 Phenol Composition EXXONMOBIL CHEMICAL PATENTS INC. 2017-03-02 US claimed
US-20170001930-A1 Cyclohexylbenzene Composition EXXONMOBIL CHEMICAL PATENTS INC. 2017-01-05 US claimed
US-20160376210-A1 Process for Making Phenol and/or Cyclohexanone EXXONMOBIL CHEMICAL PATENTS INC. 2016-12-29 US claimed
EP-3083530-A1 CYCLOHEXYLBENZENE COMPOSITION ExxonMobil Chemical Patents Inc. (US) 2016-10-26 EP claimed
EP-3083538-A2 PROCESS FOR MAKING PHENOL AND/OR CYCLOHEXANONE ExxonMobil Chemical Patents Inc. (US) 2016-10-26 EP claimed
EP-2401248-B1 PROCESS FOR PRODUCING PHENOL EXXONMOBIL CHEM PATENTS INC (US) 2016-04-20 EP claimed
WO-2015094530-A2 PROCESS FOR MAKING PHENOL AND/OR CYCLOHEXANONE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-06-25 WO claimed
WO-2015094571-A1 PHENOL COMPOSITION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-06-25 WO claimed
WO-2015094528-A1 CYCLOHEXYLBENZENE COMPOSITION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-06-25 WO claimed
EP-3626802-B1 METHOD FOR PRODUCING LIQUID COMPOSITION SUMITOMO CHEMICAL CO (JP) 2024-12-25 EP disclosed
CN-117623904-A Production process of high-purity loxoprofen sodium 宣城美诺华药业有限公司 2024-03-01 CN disclosed
US-11046886-B2 Method for producing liquid composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 US disclosed
CN-111051470-B Process for preparing liquid composition 住友化学株式会社 2020-11-10 CN disclosed
US-20080234334-A1 1,4 DIAMINO BICYCLIC RETIGABINE ANALOGUES AS POTASSIUM CHANNEL MODULATORS VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2008-09-25 US disclosed
WO-2008075152-A1 1- [4- (SULFONYL) -PHENYL] -5- (BENZYL) -IH-I, 2, 4-TRIAZOL DERIVATIVES AS INHIBITORS OF CARBONIC ANHYDRASE FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION PFIZER PRODUCTS INC. (US) 2008-06-26 WO disclosed
WO-2008075148-A2 TRICYCLIC INHIBITORS OF CARBONIC ANHYDRASE PFIZER PRODUCTS INC. (US) 2008-06-26 WO disclosed
WO-2008066900-A1 1,4 DIAMINO BICYCLIC RETIGABINE ANALOGUES AS POTASSIUM CHANNEL MODULATORS VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2008-06-05 WO disclosed
WO-2008017932-A2 HETEROCYCLES USEFUL AS INHIBITORS OF CARBONIC ANHYDRASE PFIZER PRODUCTS INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10259759-B2 Cyclohexylbenzene composition CYP1B1, CYP4B1, MCCC2 MEN1 4576/4885KMT2A 1282/4885GRIA4 3704/4885
US-20170001930-A1 Cyclohexylbenzene Composition CYP1B1, CYP4B1, MCCC2 MEN1 4576/4885KMT2A 1282/4885GRIA4 3704/4885
US-20170057895-A1 Phenol Composition CYP4B1, CYP26B1, CYP1B1 MEN1 4559/4885KMT2A 1311/4885GRIA4 3643/4885
US-20080234334-A1 1,4 DIAMINO BICYCLIC RETIGABINE ANALOGUES AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNB1, KCNA1 MEN1 962/4885KMT2A 254/4885GRIA4 185/4885
US-20160376210-A1 Process for Making Phenol and/or Cyclohexanone CYP4B1, CYP26B1, CYP1B1 MEN1 4296/4885KMT2A 1350/4885GRIA4 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.